Akari Therapeutics Plc 10-K for FY2024
Akari Therapeutics Plc (AKTX)
10-K
2025-04-15
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
Akari Therapeutics Plc filed this 10-K on April 15, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $19.79M
- compared with a net loss of $10.01M a year earlier
- Diluted EPS
- $0.00
- compared with $0.00 a year earlier